SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

Alexander & Turner Inc. Studio

Shannon Associates

Platelet Stimulating Agent 

Prev Next
Previous

Activated Platelets in aHUS

medical illustration of Disease caused by decreased platelet production can be augmented by platelet-stimulating agents that interact with the transmembrane domains of the thrombopoietin receptors, thereby complementing native thrombopoietin that binds with the extracellular domains.
Next medical illustration of The neurovascular unit for Remedy Pharmaceuticals investor relations. Remedy’s drug candidate reduces brain swelling and hemorrhage following traumatic injury. The brain microvessels, astrocytes, pericytes, neurons, microglia and the extracellular matrix form functional neurovascular units to maintain a precisely regulated microenvironment for reliable neuronal signaling.

The Neurovascular Unit

Disease caused by decreased platelet production can be augmented by platelet-stimulating agents that interact with the transmembrane domains of the thrombopoietin receptors, thereby complementing native thrombopoietin that binds with the extracellular domains.

Keywords: Airbrush, Color, 3D, Advertising / Marketing, Cell biology / Histology, Disease Management, Pharmacology, Mechanism of Action (MOA)

© Cynthia Turner